Literature DB >> 9472879

Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study.

L H Kuller1, L Shemanski, T Manolio, M Haan, L Fried, N Bryan, G L Burke, R Tracy, R Bhadelia.   

Abstract

BACKGROUND AND
PURPOSE: We determined the relationship between apolipoprotein (Apo)E, MRI, and low cognitive scores.
METHODS: The relationship between age, education, ApoE genotype, MRI examination of the brain, subclinical and clinical cardiovascular disease, and low (<80) score on the Modified Mini-Mental State Examination (3MSE, as modified by Teng and Chui) was evaluated for 3469 black and white participants in the Cardiovascular Health Study (CHS) in years 5 and 6 of the study. The participants were followed for up to 3 years.
RESULTS: The prevalence of scores <80 in years 5 and 6 of the CHS was 8.2% for participants without and 20.4% for those with prior history of stroke. Age, race, and education were important determinants of low 3MSE scores. The prevalence of ApoE-4 (odds ratio [OR], 1.6 [1.1 to 2.1]) was directly related to scores <80, as was high ventricular volume (OR, 1.6 [1.2 to 2.3]), high white matter grade (OR, 1.4 [1.1 to 1.9]), and infarctlike lesions (OR, 1.6 [1.2 to 2.1]) on the MRI in the multivariate analysis. A five-point or greater decline in scores over up to 3 years was more often observed for participants with low 3MSE scores at year 5, at older ages, with lower education, and experiencing incident stroke (OR, 3.6 [1.2 to 10.6]), ApoE-4 genotype (OR, 1.8 [1.4 to 2.3]), and with MRI findings of high ventricular volume (OR, 2.0 [1.5 to 2.7]), and infarctlike lesions (OR, 1.2 [0.9 to 1.5]).
CONCLUSIONS: These results demonstrate that vascular changes on MRI, measures of brain atrophy, ApoE-4, and age, education, and race are associated with low cognitive scores among older individuals. The MRI of the brain provides valuable information related to cognitive tests and decline over time. The potential exists for using MRI measurements to identify high-risk individuals for dementia and to test potential interventions to reduce the risk of dementia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9472879     DOI: 10.1161/01.str.29.2.388

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  108 in total

1.  Issues of clinical trial design and data interpretations in hypertension.

Authors:  L H Kuller
Journal:  Curr Hypertens Rep       Date:  1999-08       Impact factor: 5.369

Review 2.  Patterns of compensation and vulnerability in normal subjects at risk of Alzheimer's disease.

Authors:  Oscar L Lopez; James T Becker; Lewis H Kuller
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

3.  Diagnosis, risk factors, and treatment of vascular dementia.

Authors:  Oscar L Lopez; Lewis H Kuller; James T Becker
Journal:  Curr Neurol Neurosci Rep       Date:  2004-09       Impact factor: 5.081

4.  Markers of cholesterol metabolism in the brain show stronger associations with cerebrovascular disease than Alzheimer's disease.

Authors:  Timothy M Hughes; Lewis H Kuller; Oscar L Lopez; James T Becker; Rhobert W Evans; Kim Sutton-Tyrrell; Caterina Rosano
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

5.  Slower gait, slower information processing and smaller prefrontal area in older adults.

Authors:  Caterina Rosano; Stephanie A Studenski; Howard J Aizenstein; Robert M Boudreau; William T Longstreth; Anne B Newman
Journal:  Age Ageing       Date:  2011-09-28       Impact factor: 10.668

6.  The association of genetic variants in interleukin-1 genes with cognition: findings from the cardiovascular health study.

Authors:  K S Benke; M C Carlson; B Q Doan; J D Walston; Q L Xue; A P Reiner; L P Fried; D E Arking; A Chakravarti; M D Fallin
Journal:  Exp Gerontol       Date:  2011-09-24       Impact factor: 4.032

7.  Relationship of ethnicity, age, education, and reading level to speed and executive function among HIV+ and HIV- women: the Women's Interagency HIV Study (WIHS) Neurocognitive Substudy.

Authors:  Jennifer J Manly; Clifford Smith; Howard A Crystal; Jean Richardson; Elizabeth T Golub; Ruth Greenblatt; Esther Robison; Eileen M Martin; Mary Young
Journal:  J Clin Exp Neuropsychol       Date:  2011-08-23       Impact factor: 2.475

8.  Cognitive Aging in Black and White Americans: Cognition, Cognitive Decline, and Incidence of Alzheimer Disease Dementia.

Authors:  Jennifer Weuve; Lisa L Barnes; Carlos F Mendes de Leon; Kumar B Rajan; Todd Beck; Neelum T Aggarwal; Liesi E Hebert; David A Bennett; Robert S Wilson; Denis A Evans
Journal:  Epidemiology       Date:  2018-01       Impact factor: 4.822

9.  The role of functional status on the relationship between blood pressure and cognitive decline: the Cardiovascular Health Study.

Authors:  Lindsay M Miller; Carmen A Peralta; Annette L Fitzpatrick; Chenkai Wu; Bruce M Psaty; Anne B Newman; Michelle C Odden
Journal:  J Hypertens       Date:  2019-09       Impact factor: 4.844

10.  Long-term cognitive decline and mortality after carotid endarterectomy.

Authors:  Parthasarathy D Thirumala; Rajiv P Reddy; Oscar L Lopez; Yue-Fang Chang; James T Becker; Lewis H Kuller
Journal:  Clin Neurol Neurosurg       Date:  2020-04-06       Impact factor: 1.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.